What is the equivalent dose of escitalopram (Lexapro) for an adult patient taking 10 mg paroxetine (Paxil) with normal hepatic and renal function?

SSRI Dose Equivalency: Paroxetine to Escitalopram

Paroxetine 10 mg daily is approximately equivalent to escitalopram 5–10 mg daily, with 10 mg escitalopram being the more commonly used equivalent dose in clinical practice.

Dose Equivalency Rationale

The evidence base for direct SSRI dose equivalency is limited, but the following framework guides conversion:

• Paroxetine 10 mg represents a subtherapeutic or low starting dose, as the minimal effective dose for depression is 20 mg/day, with most patients requiring 20–50 mg/day for optimal response 1
• Escitalopram 10 mg is the standard starting dose for major depressive disorder and anxiety disorders, with a therapeutic range of 10–20 mg/day 2
• In head-to-head trials, escitalopram 20 mg demonstrated superior efficacy to paroxetine 20 mg across multiple symptom dimensions in social anxiety disorder, suggesting escitalopram may have greater potency on a milligram-per-milligram basis 3

Practical Conversion Algorithm

When switching from paroxetine 10 mg to escitalopram:

1. Start escitalopram at 10 mg daily as the most appropriate equivalent dose, given that:

   • Paroxetine 10 mg is below the standard therapeutic dose of 20 mg 1
   • Escitalopram 10 mg is the established starting dose with demonstrated efficacy 2
   • This approach minimizes risk of under-treatment while avoiding excessive dosing

2. Consider starting at escitalopram 5 mg daily only if:

   • The patient is elderly (>60 years), where lower starting doses are recommended 4
   • The patient experienced significant side effects on paroxetine 10 mg
   • There is concern about tolerability during the cross-taper

3. Titrate to escitalopram 10–20 mg based on response within 7–10 days after steady-state is achieved 2

Critical Pharmacokinetic Differences

Escitalopram has more favorable pharmacokinetics than paroxetine:

• Escitalopram reaches steady-state in 7–10 days (half-life 27–33 hours) 2
• Escitalopram has minimal drug-drug interactions and negligible CYP inhibition 2
• Escitalopram exhibits linear, dose-proportional pharmacokinetics in the 10–30 mg range 2
• The therapeutic plasma concentration range for escitalopram is 15–80 ng/mL 4

Safety Considerations During Conversion

Taper paroxetine gradually to avoid discontinuation syndrome:

• Reduce paroxetine by 50% while initiating escitalopram, then discontinue paroxetine after 1 week
• Monitor for withdrawal symptoms including irritability, dizziness, sensory disturbances, and anxiety 4

Monitor for QT prolongation with escitalopram, particularly:

• In patients >60 years, where maximum doses should be reduced 4
• In patients with pre-existing cardiac conduction abnormalities 4

Avoid dose escalation beyond escitalopram 10 mg for at least 3–4 weeks to allow adequate time for therapeutic response assessment, as steady-state is achieved within 7–10 days but clinical response may take longer 2